MSK Paul Calabresi Career Development Award for Clinical Oncology
MSK Paul Calabresi Career Development Award for Clinical Oncology
批准号:
9788288
负责人:
Renier Joseph Brentjens
金额:
$80.8万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-04 至 2020-08-31
关键词:
Advisory CommitteesApplications GrantsAppointmentAwardCancer BiologyClinicalClinical OncologyClinical TrialsDevelopmentEducational CurriculumFacultyFundingInstitutionInternetInternshipsK-Series Research Career ProgramsMalignant NeoplasmsMaster&aposs DegreeMedicineMemorial Sloan-Kettering Cancer CenterMentorsPositioning AttributeProcessProgram ReviewsResearchRotationSECTM1 geneSchoolsScienceTrainingTraining ProgramsTranslational ResearchUnited States National Institutes of HealthVisitanticancer researchbaseclinical investigationdesignprogramssymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This is a revised K12 application for the Paul Calabresi Career Development Award for Clinical Oncology to set up a training program for clinical translational research at Memorial Sloan Kettering Cancer Center (MSK). We propose to establish a uniquely universal training program to expand over all departments engaged in cancer research at the institution. We have designed this proposed training program to be restricted to candidates with an MD or DO degree alone. This program will provide 3 years of junior faculty funding to selected scholars. The program will solicit applications from senior fellows moving into junior faculty positions and junior faculty within the first 3 years of their appointments at MSK as well as similarly qualified candidates from other training programs through an internet-based application process. Applications for this program will be reviewed by the K12 internal advisory committee who will judge the merits of the applicants and select the 3-4 best applicants annually. Additional funding to support a program of 12 scholars annually in years 4 and 5 of the award will be provided through guaranteed matched funding support by MSK. Applications from scholars selected by the advisory committee will subsequently be evaluated by an established K12 educational committee who will design a personalized curriculum for each selected candidate. This curriculum will include a pre-established core curriculum requisite for all scholars with additional elective courses derived from available courses offered by the Louis V. Gerstner Graduate School of Biomedical Science. Significantly, over the first year of funding from this award, the K12 educational committee will establish a Master's Degree in Clinical Investigation to be awarded to all scholars who successfully complete the program. The core curriculum will include the the Cornell CTSC, curriculum, MSK cancer biology and cancer medicine courses, as well as level I mentored grant application and level II NIH R class grant application training programs. Additionally the core curriculum will include training in clinical trial development, and for 2nd and 3rd year scholars, rotational 6 month internships on relevant MSK clinical trial approval committees. The program progress will be evaluated monthly by a K12 internal advisory committee as well as an established external advisory committee who will evaluate the program every six months including an onsite visit during the planned annual K12 research symposium. Similarly, K12 scholars will be asked to review the program and their mentors every 6 months.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 4: Chimeric Antigen Receptor T Cell Therapy for the Treatment of Acute Myeloid Leukemia
-
批准号:10474300
-
项目类别:
-
资助金额:$36.77万
-
财政年份:2021
-
负责人:Renier Joseph Brentjens
-
依托单位:
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
-
批准号:10380107
-
项目类别:
-
资助金额:$63.07万
-
财政年份:2021
-
负责人:Renier Joseph Brentjens
-
依托单位:
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
-
批准号:10523835
-
项目类别:
-
资助金额:$58.5万
-
财政年份:2021
-
负责人:Renier Joseph Brentjens
-
依托单位:
MSK Paul Calabresi Career Development Award for Clinical Oncology
-
批准号:8875305
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2015
-
负责人:Renier Joseph Brentjens
-
依托单位:
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
-
批准号:8143046
-
项目类别:
-
资助金额:$195.15万
-
财政年份:2010
-
负责人:Renier Joseph Brentjens
-
依托单位:
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
-
批准号:8019552
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2009
-
负责人:Renier Joseph Brentjens
-
依托单位:
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
-
批准号:8214708
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2009
-
负责人:Renier Joseph Brentjens
-
依托单位:
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
-
批准号:8444267
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2009
-
负责人:Renier Joseph Brentjens
-
依托单位:
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
-
批准号:7634005
-
项目类别:
-
资助金额:$39.34万
-
财政年份:2009
-
负责人:Renier Joseph Brentjens
-
依托单位:
Genetic Targeting of T cells to B cell malignancies
-
批准号:6951500
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2003
-
负责人:Renier Joseph Brentjens
-
依托单位:
Genetic Targeting of T cells to B cell malignancies
-
批准号:6785519
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2003
-
负责人:Renier Joseph Brentjens
-
依托单位:
Genetic Targeting of T cells to B cell malignancies
-
批准号:6687407
-
项目类别:
-
资助金额:$13.42万
-
财政年份:2003
-
负责人:Renier Joseph Brentjens
-
依托单位:
Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients
-
批准号:9754071
-
项目类别:
-
资助金额:$30.45万
-
财政年份:--
-
负责人:Renier Joseph Brentjens
-
依托单位:
Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients
-
批准号:9565736
-
项目类别:
-
资助金额:$32.59万
-
财政年份:--
-
负责人:Renier Joseph Brentjens
-
依托单位: